Wetherby Asset Management Inc. Buys 733 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wetherby Asset Management Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.1% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 24,362 shares of the healthcare conglomerate’s stock after purchasing an additional 733 shares during the period. UnitedHealth Group accounts for about 0.7% of Wetherby Asset Management Inc.’s investment portfolio, making the stock its 17th biggest holding. Wetherby Asset Management Inc.’s holdings in UnitedHealth Group were worth $12,424,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in UNH. Advocacy Wealth Management Services LLC lifted its position in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. lifted its position in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares in the last quarter. Rise Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $38,000. Evolution Advisers Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $38,000. Finally, Cordant Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $45,000. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on UNH. Morgan Stanley boosted their target price on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective on the stock. in a research note on Thursday, May 26th. They noted that the move was a valuation call. UBS Group boosted their price objective on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Finally, Oppenheimer boosted their price objective on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Stock Down 0.3 %

Shares of NYSE:UNH opened at $524.34 on Friday. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The stock has a market cap of $490.46 billion, a P/E ratio of 27.38, a price-to-earnings-growth ratio of 1.64 and a beta of 0.76. The business’s 50 day moving average is $528.73 and its 200 day moving average is $510.20. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter in the prior year, the firm earned $4.70 earnings per share. UnitedHealth Group’s revenue was up 12.6% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be issued a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a yield of 1.26%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the sale, the executive vice president now owns 8,104 shares in the company, valued at approximately $4,043,896. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 465 shares of the stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. Insiders sold a total of 140,324 shares of company stock worth $75,086,185 over the last 90 days. Company insiders own 0.40% of the company’s stock.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.